On June 17, 2022, the World Trade Organization (WTO) Ministerial Conference issued a “Draft Ministerial Decision on the TRIPS Agreement,” addressing the requirements established in Articles 31 and 39.3 of the TRIPS Agreement in the context of the COVID-19 pandemic. The Decision provides several clarifications regarding the process by which member countries may “authorize the use of the subject matter of a patent” without the consent of the right holder for the purposes of “production and supply of COVID-19 vaccines.” The decision provides guidance to countries considering the use of legal mechanisms, particularly compulsory licenses, to transfer vaccine technology with the goal of increasing the number of doses of COVID-19 vaccine available to underserved populations, especially in lower-income countries.
CITATION STYLE
Rutschman, A. S. (2023). Ministerial Decision on the Trips Agreement (WTO). International Legal Materials, 62(2), 289–294. https://doi.org/10.1017/ilm.2022.47
Mendeley helps you to discover research relevant for your work.